These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8275033)

  • 1. Factors affecting hair regrowth after bone marrow transplantation.
    Vowels M; Chan LL; Giri N; Russell S; Lam-Po-Tang R
    Bone Marrow Transplant; 1993 Oct; 12(4):347-50. PubMed ID: 8275033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth.
    Baker BW; Wilson CL; Davis AL; Spearing RL; Hart DN; Heaton DC; Beard ME
    Bone Marrow Transplant; 1991 Jan; 7(1):43-7. PubMed ID: 2043877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
    Ljungman P; Hassan M; Békássy AN; Ringdén O; Oberg G
    Bone Marrow Transplant; 1995 Jun; 15(6):869-71. PubMed ID: 7581083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of bone marrow transplantation on dental status in children with leukaemia.
    Uderzo C; Fraschini D; Balduzzi A; Galimberti S; Arrigo C; Biagi E; Pignanelli M; Nicolini B; Rovelli A
    Bone Marrow Transplant; 1997 Nov; 20(10):865-9. PubMed ID: 9404928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
    Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
    Hamon MD; Gale RF; Macdonald ID; Smith OP; Collis CH; Skeggs DB; Gandhi L; Prentice HG
    Bone Marrow Transplant; 1993 Sep; 12(3):233-6. PubMed ID: 8241982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
    Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
    Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes.
    Rubie H; Attal M; Demur C; Brousset P; Duchayne E; Rigal-Huguet F; Dastugue N; Robert A
    Bone Marrow Transplant; 1994 Jun; 13(6):759-62. PubMed ID: 7920311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late effects in children after bone marrow transplantation: a review.
    Locatelli F; Giorgiani G; Pession A; Bozzola M
    Haematologica; 1993; 78(5):319-28. PubMed ID: 8314162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
    Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone function and treatment following bone marrow transplant for neuroblastoma.
    Olshan JS; Willi SM; Gruccio D; Moshang T
    Bone Marrow Transplant; 1993 Oct; 12(4):381-5. PubMed ID: 8275038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.